OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis
Peter D. Craggs, Luiz Pedro S. de Carvalho
Current Opinion in Microbiology (2022) Vol. 69, pp. 102191-102191
Open Access | Times Cited: 13

Showing 13 citing articles:

Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy
Jiang Pi, Dongsheng Chen, Jiajun Wang, et al.
Pharmacological Research (2024) Vol. 208, pp. 107379-107379
Open Access | Times Cited: 7

Free Energy Barriers for Passive Drug Transport through the Mycobacterium tuberculosis Outer Membrane: A Molecular Dynamics Study
Ilya S. Steshin, Alexander V. Vasyankin, Ekaterina A. Shirokova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1006-1006
Open Access | Times Cited: 4

Machine Learning Prediction of Mycobacterial Cell Wall Permeability of Drugs and Drug-like Compounds
Eugene V. Radchenko, Grigory V. Antonyan, Stanislav K. Ignatov, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 633-633
Open Access | Times Cited: 9

Conformational Dynamics and Stability of Bilayers Formed by Mycolic Acids from the Mycobacterium tuberculosis Outer Membrane
L. A. Savintseva, Ilya S. Steshin, Alexander Avdoshin, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1347-1347
Open Access | Times Cited: 9

Artificial intelligence in tuberculosis: a new ally in disease control
Mairi McClean, Traian Constantin Panciu, Christoph Lange, et al.
Breathe (2024) Vol. 20, Iss. 3, pp. 240056-240056
Open Access | Times Cited: 3

Ligand-based virtual screening and biological evaluation of inhibitors of Mycobacterium tuberculosis H37Rv
Pavel V. Pogodin, Elena G. Salina, Victor V. Semenov, et al.
SAR and QSAR in environmental research (2024) Vol. 35, Iss. 1, pp. 53-69
Closed Access | Times Cited: 2

Temperature-Induced Restructuring of Mycolic Acid Bilayers Modeling the Mycobacterium tuberculosis Outer Membrane: A Molecular Dynamics Study
Alexander V. Vasyankin, С. В. Пантелеев, Ilya S. Steshin, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 696-696
Open Access | Times Cited: 2

Membrane-active and DNA binding related double-action antimycobacterial mechanism of antimicrobial peptide W3R6 and its synthetic analogs
Xiaorui Wang, Liubin Feng, Mengmiao Li, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130415-130415
Closed Access | Times Cited: 4

The significance of persisters in tuberculosis drug discovery: Exploring the potential of targeting the glyoxylate shunt pathway
Anjali Negi, Rashmi Sharma
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116058-116058
Closed Access | Times Cited: 3

Editorial overview: Recent advances in antimicrobial drug discovery and resistance
P. David Rogers, Richard Lee
Current Opinion in Microbiology (2022) Vol. 71, pp. 102242-102242
Open Access | Times Cited: 2

Page 1

Scroll to top